Intellectual property is the foundation of biotech success. Discover how platform-driven IP strategies, licensing frameworks, and strategic collaborations can amplify valuation, attract investors, and accelerate commercialization. Learn how Hylton Rodic Law helps biotech innovators protect the science, structure the deal, and scale the business.

Strong patents aren't always enough. In biotech and pharma, success hinges on how well your IP tells a story. Learn why great inventions fail in the market, how to craft a compelling IP narrative, and what investors and licensing partners really want to hear. Discover Hylton-Rodic Law’s approach to building winning patent strategies.

Intellectual property risks are rising in venture studio models, often unnoticed until it’s too late. This guide explains how to structure IP ownership, avoid earnout traps, and protect trade secrets before deals go sideways. Startups, investors, and studios: don’t skip this legal checklist.